Access comprehensive financial analyses and make smarter investments - get the Manual of Investments on Amazon!

KMB

Key Things to Consider Before Investing in Kimberly-Clark (KMB)

Kimberly-Clark logged a 1.3% change during today's afternoon session, and is now trading at a price of $103.7 per share.

Kimberly-Clark returned losses of -25.3% last year, with its stock price reaching a high of $150.45 and a low of $99.22. Over the same period, the stock underperformed the S&P 500 index by -37.0%. AThe company's 50-day average price was $116.98. Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care products in the United States. Based in Dallas, TX, the Large-Cap Consumer Discretionary company has 38,000 full time employees. Kimberly-Clark has offered a 4.9% dividend yield over the last 12 months.

The Company's Revenues Are Declining:

2019 2020 2021 2022 2023 2024
Revenue (M) $18,450 $19,140 $19,440 $20,175 $20,431 $20,058
Gross Margins 33% 36% 31% 31% 34% 36%
Net Margins 12% 12% 9% 10% 9% 13%
Net Income (M) $2,157 $2,352 $1,814 $1,934 $1,764 $2,545
Net Interest Expense (M) $261 $252 $256 $282 $293 $270
Depreciation & Amort. (M) $917 $796 $766 $754 $753 $773
Diluted Shares (M) 346 342 339 338 339 337
Earnings Per Share $6.24 $6.87 $5.35 $5.72 $5.21 $7.55
EPS Growth n/a 10.1% -22.13% 6.92% -8.92% 44.91%
Avg. Price $113.35 $127.64 $124.85 $126.0 $121.51 $103.63
P/E Ratio 18.05 18.5 23.21 21.99 23.28 13.67
Free Cash Flow (M) $1,527 $2,512 $1,723 $1,857 $2,776 $2,513
CAPEX (M) $1,209 $1,217 $1,007 $876 $766 $721
EV / EBITDA 11.86 12.79 15.19 14.74 15.52 10.38
Total Debt (M) $7,747 $8,364 $8,574 $8,422 $7,984 $7,443
Net Debt / EBITDA 1.87 2.0 2.5 2.33 2.23 1.61
Current Ratio 0.73 0.8 0.82 0.78 0.82 0.8

Kimberly-Clark has wider gross margins than its peer group and positive EPS growth. Additionally, the company's financial statements display generally positive cash flows and healthy leverage levels. However, the firm suffers from slight revenue growth and decreasing reinvestment in the business and not enough current assets to cover current liabilities because its current ratio is 0.8.

an Increase in Expected Earnings Improves Its Value Outlook but Priced Beyond Its Margin of Safety:

Kimberly-Clark has a trailing twelve month P/E ratio of 19.8, compared to an average of 20.93 for the Consumer Discretionary sector. Based on its EPS guidance of $7.63, the company has a forward P/E ratio of 15.3. The 2.9% compound average growth rate of Kimberly-Clark's historical and projected earnings per share yields a PEG ratio of 6.79. This suggests that these shares are overvalued. Furthermore, Kimberly-Clark is likely overvalued compared to the book value of its equity, since its P/B ratio of 25.84 is higher than the sector average of 2.93. The company's shares are currently trading 403.9% below their Graham number. Ultimately, Kimberly-Clark's strong cash flows, decent earnings multiple, and healthy debt levels factor towards it being fairly valued, its elevated P/B ratio notwithstanding.

Kimberly-Clark Has an Average Rating of Hold:

The 16 analysts following Kimberly-Clark have set target prices ranging from $100.0 to $162.0 per share, for an average of $128.62 with a hold rating. The company is trading -19.4% away from its average target price, indicating that there is an analyst consensus of some upside potential.

Kimberly-Clark has an average amount of shares sold short because 3.1% of the company's shares are sold short. Institutions own 83.8% of the company's shares, and the insider ownership rate stands at 0.19%, suggesting a small amount of insider investors. The largest shareholder is Vanguard Group Inc, whose 12% stake in the company is worth $4,203,241,814.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS